Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 8.07
+0.23 (2.93%)
May 13, 2025, 5:29 PM CET
Vicore Pharma Holding AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 6 | 109.35 | - | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -94.25% | - | - | - | - | - | Upgrade
|
| Gross Profit | 6 | 109.35 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 54.69 | 50.44 | 44.6 | 37.53 | 21.61 | 24.99 | Upgrade
|
| Research & Development | 259.8 | 249.26 | 276.29 | 249.97 | 271.81 | 142.02 | Upgrade
|
| Other Operating Expenses | -3.43 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 311.06 | 299.71 | 320.89 | 287.49 | 293.42 | 167.01 | Upgrade
|
| Operating Income | -305.07 | -190.36 | -320.89 | -287.49 | -293.42 | -167.01 | Upgrade
|
| Interest Expense | -26.41 | -0.01 | -0 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 19.04 | 21.08 | 10.54 | 0.91 | 0.65 | 0.82 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.4 | 0.4 | -0.62 | -1.75 | -1.83 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -312.04 | -168.89 | -310.97 | -288.34 | -294.61 | -166.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.36 | -0.47 | -2.12 | 1.41 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 17.54 | Upgrade
|
| Pretax Income | -312.04 | -168.89 | -311.33 | -288.81 | -296.74 | -147.32 | Upgrade
|
| Income Tax Expense | -0.16 | -0.26 | -0.38 | -0.38 | -0.25 | -0.45 | Upgrade
|
| Net Income | -311.88 | -168.63 | -310.94 | -288.42 | -296.48 | -146.86 | Upgrade
|
| Net Income to Common | -311.88 | -168.63 | -310.94 | -288.42 | -296.48 | -146.86 | Upgrade
|
| Shares Outstanding (Basic) | 167 | 137 | 97 | 72 | 70 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 167 | 137 | 97 | 72 | 70 | 54 | Upgrade
|
| Shares Change (YoY) | 59.58% | 41.72% | 33.71% | 3.64% | 28.44% | 26.04% | Upgrade
|
| EPS (Basic) | -1.87 | -1.23 | -3.22 | -3.99 | -4.25 | -2.71 | Upgrade
|
| EPS (Diluted) | -1.87 | -1.23 | -3.22 | -3.99 | -4.25 | -2.71 | Upgrade
|
| Free Cash Flow | -274.14 | -164.95 | -249.58 | -299.92 | -265.17 | -119.94 | Upgrade
|
| Free Cash Flow Per Share | -1.65 | -1.21 | -2.58 | -4.15 | -3.81 | -2.21 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -5088.69% | -174.09% | - | - | - | - | Upgrade
|
| Profit Margin | -5202.40% | -154.22% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -4572.86% | -150.85% | - | - | - | - | Upgrade
|
| EBITDA | -303.1 | -188.12 | -317.47 | -283.88 | -290.06 | -163.65 | Upgrade
|
| EBITDA Margin | - | -172.04% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 1.96 | 2.24 | 3.42 | 3.61 | 3.36 | 3.36 | Upgrade
|
| EBIT | -305.07 | -190.36 | -320.89 | -287.49 | -293.42 | -167.01 | Upgrade
|
| EBIT Margin | - | -174.09% | - | - | - | - | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.